SCHEMBL14033166

SCHEMBL14033166

CNC(=O)CNC(=O)c1cnn2cc(Cc3ccc(Cl)c(Cl)c3)cnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 7/20 0.44
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
IRAK4 Q9NWZ3 4/20 0.38
HPGD P15428 2/20 0.37
LMNA P02545 1/20 0.37
CYP1A1 P04798 1/20 0.36
LIPC P11150 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
VEGFA P15692 1/20 0.36
FLT1 P17948 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
EGLN3 Q9H6Z9 1/20 0.36
PDE10A Q9Y233 1/20 0.35
TAOK1 Q7L7X3 1/20 0.35
TAOK3 Q9H2K8 1/20 0.35
PLA2G1B P04054 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033169 0.89 PDE2A (0.42) PDE2AALDH1A1HSD17B10KDM4EPKM
SCHEMBL4439737 0.88 PDE2A (0.43) PDE2AALDH1A1HSD17B10KDM4EPKM
SCHEMBL14048912 0.86 PDE2A (0.44) PDE2AHSD17B10KDM4EPKMIRAK4
SCHEMBL14032998 0.84 PDE2A (0.43) PDE2AALDH1A1HSD17B10KDM4EPKM
SCHEMBL4555125 0.84 IRAK4 (0.43) PDE2AHSD17B10KDM4EPKMIRAK4
SCHEMBL14033688 0.83 PDE2A (0.46) PDE2AALDH1A1KDM4EIRAK4HPGD
SCHEMBL4553722 0.83 IRAK4 (0.43) PDE2AHSD17B10KDM4EPKMIRAK4
SCHEMBL14033167 0.83 PDE2A (0.41) PDE2AHSD17B10KDM4EPKMIRAK4
SCHEMBL14033330 0.83 PDE2A (0.41) PDE2AHSD17B10KDM4EPKMIRAK4
SCHEMBL4555090 0.83 KDM5A (0.45) PDE2AALDH1A1HSD17B10KDM4EIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
US-20080255153-A1 New compounds BIOVITRUM AB (PUBL) (SE) 2008-10-16 US disclosed
WO-2008116898-A1 PYRAZOLO [1,5-A]PYRIMIDINES AS INHIBITORS OF STEAROYL-COA DESATURASE BIOVITRUM AB (PUBL) (SE) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255153-A1 New compounds SCD, SCD5, FADS2 PDE2A 2511/4885ALDH1A1 1498/4885HSD17B10 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.